Cosmo reports excellent final Full Year 2023 financial results. Increases operating profit guidance for 2024. Dividend of € 2.00 per share will be proposed at EGM on 5 July 2024

Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced its final audited results for the financial year 2023.